Inventor
CHENG ALAN C
US20 patents
⚠️ This page may combine multiple inventors who share the name “CHENG ALAN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
12 patentsUS10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9845310B2Dec 19, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656997B2May 23, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US10150760B2Dec 11, 2018
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
AMGEN INC8 citations84
US9988369B2Jun 5, 2018
Heterocyclic triazole compounds as agonists of the APJ receptor
AMGEN INC8 citations83
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US11046680B1Jun 29, 2021
Heteroaryl-substituted triazoles as APJ receptor agonists
AMGEN INC2 citations62
US10736883B2Aug 11, 2020
Triazole furan compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US10689367B2Jun 23, 2020
Triazole pyridyl compounds as agonists of the APJ receptor
AMGEN INC1 citations62
MERCK SHARP & DOHME LLC
3 patentsUS11702467B2Jul 18, 2023
High affinity antibodies targeting tau phosphorylated at serine 413
MERCK SHARP & DOHME LLC1 citations57
US12528786B2Jan 20, 2026
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations45
US12459927B2Nov 4, 2025
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations44